CORPORATES SMS Pharmaceuticals successfully concludes USFDA inspection at Vizag API facility Dec 12, 2025
STOCK MARKET SMS Pharmaceuticals shares jump 4% as VKT Pharma secures US FDA approval for reformulated Ranitidine Nov 26, 2025
CORPORATES SMS Pharmaceuticals’ VKT Pharma receives US FDA approval for reformulated Ranitidine Nov 26, 2025
SMS Pharmaceuticals Q1 Results: Revenue jumps 19% YoY to Rs 196.05 crore, net profit up14% YoY Aug 9, 2025
SMS Pharmaceuticals share jump 6% after its Hyderabad facility clears USFDA inspection with zero observations Jun 26, 2025
SMS Pharmaceuticals clears second USFDA inspection at Hyderabad lab with zero observations Jun 25, 2025